Fluticasone

Study of Fluticasone Propionate Multidose Dry Powder Inhaler Compared With Fluticasone Propionate/Salmeterol Multidose Dry Powder Inhaler

Condition:   AsthmaInterventions:   Drug: Fp MDPI;   Drug: FS MDPI;   Drug: PlaceboSponsor:   Teva Branded Pharmaceutical Products, R&D Inc.Not yet recruiting – verified November 2016 View full post on ClinicalTrials.gov: asthma | Studies received in the last 14 days

Assessing the Effects of Intranasal Fluticasone Plus Azelastine on Airway Inflammation in Patients With Asthma and Allergic Rhinitis

Conditions:   Asthma, Allergic;   Rhinitis,Allergic;   AllergyInterventions:   Drug: Azelastine-Fluticasone Nasal;   Drug: PlacebosSponsor:   University of DundeeNot yet recruiting – verified October 2016 View full post on ClinicalTrials.gov: asthma | Studies received in the last 14 days

Effects of a Orally Inhaled Fluticasone Furoate on Growth Velocity in Prepubertal, Paediatric Subjects With Asthma Over a Year

Condition:   AsthmaInterventions:   Drug: Fluticasone furoate;   Drug: Placebo;   Drug: Montelukast;   Drug: Short Acting Beta 2 AgonistSponsor:   GlaxoSmithKlineNot yet recruiting – verified August 2016 View full post on ClinicalTrials.gov: asthma | Studies received in the last 14 days

A Study to Compare the Efficacy of Fluticasone Furoate/Vilanterol Inhalation Powder With Usual Inhaled Corticosteroids (ICS)/Long Acting Beta Agonists (LABA) in Persistent Asthma

Condition:   AsthmaInterventions:   Drug: Fluticasone Furoate;   Drug: Vilanterol;   Drug: Fluticasone propionate;   Drug: Salmeterol;   Drug: Budesonide;   Drug: Formoterol FumarateSponsor:   GlaxoSmithKlineNot yet recruiting – verified May 2015 View full post on ClinicalTrials.gov: asthma | received in the last 14 days

Study to Determine the Pharmacokinetics and Tolerability of Fluticasone Propionate MDPI and Fluticasone Propionate/Salmeterol MDPI Compared to High Strength FLOVENT® DISKUS® and ADVAIR® DISKUS® in Patients With Persistent Asthma 12 Years of Age and Older

Condition:   AsthmaInterventions:   Drug: Treatment A: Fp MDPI;   Drug: Treatment B: FS MDPI;   Drug: Treatment C Flovent;   Drug: Treatment D:  AdvairSponsor:   Teva Branded Pharmaceutical Products, R&D Inc.Not yet recruiting – verified May 2015 View full post on ClinicalTrials.gov: asthma | received in the last 14 days